Prostate Cancer - Results from #26340

Common genetic variants in prostate cancer risk prediction - results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) - Abstract February 6, 2012

When is elective pelvic lymph node irradiation indicated in definitive radiotherapy for localized prostate cancer? - Abstract February 6, 2012

Quality of life associated with treatment of castration-resistant prostate cancer: A review of the literature - Abstract February 6, 2012

Chemoprevention of prostate cancer: An updated view - Abstract February 6, 2012

Testosterone and prostate - Abstract February 6, 2012

A "rolling average" multiple adaptive planning method to compensate for target volume changes in image-guided radiotherapy of prostate cancer - Abstract February 6, 2012

Use of androgen deprivation therapy in prostate cancer: Indications and prevalence - Abstract February 6, 2012

Hematological changes during androgen deprivation therapy - Abstract February 6, 2012

Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis - Abstract February 6, 2012

Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer - Abstract February 6, 2012

The Epigenetic promise for prostate cancer diagnosis - Abstract February 6, 2012

MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer - Abstract February 6, 2012

Study on the autophagy of prostate cancer PC-3 cells induced by oridonin - Abstract February 6, 2012

GU Cancers Symposium 2012 - Validation of a cell-cycle progression (CCP) gene panel to improve risk stratification in a contemporary prostatectomy cohort - Session Highlights February 6, 2012

GU Cancers Symposium 2012 - A randomized phase II study of OGX-427 + prednisone vs. prednisone alone in patients with chemotherapy-naïve metastatic castration resistant prostate cancer - Session Highlights February 6, 2012

Caveolin-1 as a potential high-risk prostate cancer biomarker - Abstract February 3, 2012

Matrine inhibits proliferation and induces apoptosis of the androgen‑independent prostate cancer cell line PC-3 - Abstract February 3, 2012

Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer - Abstract February 3, 2012

Epigenetics in prostate cancer - Abstract February 3, 2012

Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence - Abstract February 3, 2012

Page 1318 of 1437